Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CAT stock price vs TECH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TECH's multiple
Needs TECH P/E.
Implied fair value · at CAT's multiple
Needs CAT P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CATERPILLAR INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
BIO-TECHNE Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
DEERE & CO
CAT vs DE
CUMMINS INC
CAT vs CMI
Parker-Hannifin Corp
CAT vs PH
TEREX CORP
CAT vs TEX
AGCO CORP /DE
CAT vs AGCO
CNH Industrial N.V.
CAT vs CNHI
THERMO FISHER SCIENTIFIC INC.
CAT vs TMO
DANAHER CORP /DE/
CAT vs DHR
AGILENT TECHNOLOGIES, INC.
CAT vs A
WATERS CORP /DE/
CAT vs WAT
ILLUMINA, INC.
CAT vs ILMN
BRUKER CORP
CAT vs BRKR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CAT can sustain its 24.0% ROIC and 13.1% net margin despite 1.7x Debt/Equity, then hold or accumulate only on pullbacks because the stock already sits near the top of its historical band and far above the DCF range.
CAT trades at a meaningful premium to TECH on both earnings and sales multiples, despite having much larger scale and stronger profitability. The implied price of $2,949.90 versus the current $830.03 suggests a theoretical upside of 255.4%, but that output appears driven by TECH's much higher P/E rather than a clear fundamental justification for CAT.
Supporting Metrics
